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ABSTRACT
Cell migration frequently involves the formation of lamellipodial protrusions, the initiation of which
requires Rac GTPases signalling to heteropentameric WAVE regulatory complex (WRC). While Rac-
related RhoG and Cdc42 can potently stimulate lamellipodium formation, so far presumed to occur by
upstream signalling to Rac activation, we show here that the latter can be bypassed by RhoG and
Cdc42 given that WRC has been artificially activated. This evidence arises from generation of B16-F1
cells simultaneously lacking both Rac GTPases and WRC, followed by reconstitution of lamellipodia
formation with specific Rho-GTPase and differentially active WRC variant combinations. We conclude
that formation of canonical lamellipodia requires WRC activation through Rac, but can possibly be
tuned, in addition, by WRC interactions with RhoG and Cdc42.
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Introduction
Cell migration is essential for many physiological and
pathological processes, such as embryonic development,
immunity and metastasis [1–3]. Protrusion of the plasma
membrane to enable cell migration is commonly achieved
by the formation of thin branched arrays of actin filaments,
called lamellipodia [4,5]. Small GTPases of the Rac family
(i.e. Rac1, Rac2, Rac3 in mammals) are essential for lamel-
lipodia initiation and maintenance, at least in part, by
activation and continuous interaction through two binding
sites on Sra-1 (or its orthologue PIR121) embedded into
heteropentameric WAVE regulatory complex (WRC)
[6,7]. The closest relatives of Rac GTPases are RhoG and
Cdc42. Both fail to initiate lamellipodia in fibroblasts lack-
ing Rac expression [6], but can clearly promote Rac-
dependent lamellipodia formation. This activity is thought
to derive from crosstalk involving distinct Rac-GEF com-
plexes [8–11]. The inability of RhoG and Cdc42 to initiate
lamellipodia has hitherto been thought to be due to a lack
of sufficient interaction with WRC. This is because both
RhoG and Cdc42 show at best a weak interaction with Sra-
1/PIR121 [6,12], and Cdc42, as opposed to Rac1, fails to
activate native WRC in vitro [13].
Aside from Sra-1 (or PIR121), WRC is composed of
four additional subunits – WAVE2 (or its paralogues
WAVE1/WAVE3), the Sra-1/PIR121 interactor Nap1 (or
Hem1 in the hematopoietic system), Abi1 (or Abi2/Abi3)
and HSPC300 [14–17]. The Sra-1 subunit is ‘transinhibit-
ing’ the Arp2/3 complex-activating, so calledWCAdomain
located on the C-terminal end of WAVE proteins, and Rac
binding to Sra-1 outcompetes this inhibitory interaction to
release theWCAdomain,making it accessible for actin and
Arp2/3 complex binding [18]. We have recently shown
that the two aforementioned Rac binding sites on Sra-1/
PIR121 [18,19] are essential for allosteric activation of
WRC in cells [7]. However, in spite of the previously
proposed safe box model requiring two keys to allow for
WRC activation to occur [19], we have found surprisingly
specific physiological functions for the two sites in live cells.
Whereas the low affinity A site is crucial for activation
in vivo, the high affinity D site is contributing to the
efficiency of lamellipodial protrusion, but by no means as
important forWRC activation as the A site. Aside from the
apparent critical function of Rac in WRC activation, it is
less well established if or if so to what extent Rac-WRC
interactions also driveWRC recruitment to and accumula-
tion in the lamellipodium. For instance, we have also found
that lamellipodia formation can be initiated, in principle,
without direct WRC-Rac interactions once WRC is ren-
dered active, assuming at least that introduced, respective
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mutations of both A andD sites into activeWRC abolished
its interaction with Rac entirely [7,19]. This is consistent
with the fact that deleting the CAAX-box in Rac1, which is
crucial for plasma membrane association, does impair, but
not abolish lamellipodia formation in Rac1 knockout (KO)
fibroblasts [6]. In spite of the absence of an unequivocal,
alternative mechanism of WRC recruitment, these data
suggest that activation and lamellipodial targeting of
WRC might potentially be separable. An example of such
a separation clearly constitutes the related GTPase Cdc42,
which mediates activation of its downstream effectors
FMNL2 and −3 as prerequisite of their lamellipodial target-
ing [20,21], which however can fully occur with active
variants completely lacking GTPase interaction surfaces
([22] and unpublished data). Therefore, effector recruit-
ment to lamellipodia is possible, in principle, without
engagement of a given GTPase in spite of its established
relevance in effector activation. Here, we have developed
novel cell lines to compare the capability of lamellipodia
formation by activatedWRC in the absence versus presence
of endogenous Rac GTPases.
Results
Rac – WRC interactions at the plasma membrane
are dispensable for lamellipodia formation
We sought to test if plasma membrane insertion of the
prenyl group of Rac1 is required for lamellipodia induc-
tion in B16-F1 cells. For this, we expressed constitutively
active (Q61L), myc-tagged Rac1 or an identical construct
lacking the CAAX-box essential for C-terminal prenyla-
tion in B16-F1 cells lacking Rac1/2/3 (clone#1 [7]). In
analogy to our previously published experiments
employing fibroblasts genetically deleted for Rac1 [6],
deletion of the CAAX-box reduced, but did not abolish
lamellipodia formation in these conditions. More speci-
fically, these structures were induced with overall slightly
reduced frequency, and the majority of them (roughly
60%) appeared to be immature, according to the pre-
viously established categorization of underdeveloped
lamellipodia [7]. In contrast, the majority of cells expres-
sing full length, constitutively active (Q61L) Rac1 har-
boured fully developed lamellipodia (Figure S1(a,b)).
These data suggest that the same effects seen in Rac1−/−
fibroblasts [6] were not cell-type specific, and could not
potentially be explained by remnants of Rac2 or −3
protein expressed perhaps at undetectable levels from
respective genes not targeted in these fibroblasts.
In analogy, we assembled WRCs in Sra-1/PIR121 KO
cells (clone #3) harbouring a Sra-1 variant mediating con-
stitutive WRC activation, but lacking functional Rac bind-
ing sites (A + D site WCA* [7], and Figure S1(e)). In this
construct, specific pointmutations abolished the binding of
Rac to the A site (C179R/R190D) and D site (Y967A)
[7,18,19], whereas the WCA* mutation (L697D/Y704D/
L841A/F844A/W845A) in the WH2- and C-region (W
and C) contact sites of Sra-1 prevented the ‘transinhibitory’
binding of Sra-1 to the WCA domain of WAVE, which is
then released for activating Arp2/3 complex [7,18]. We
found that Sra-1/PIR121 KO cells (clone #3) harbouring
A + D site WCA*-mutated WRC can still rescue lamelli-
podia formation, albeit at strongly compromised frequency
[7]. Once formed though, and although compromised,
these lamellipodia can still accumulate WRC at their tips
(Figure S1(c), see also [7]), and mediate continuous pro-
trusion that is less smooth though than with lamellipodia
driven byWRCs harbouringWT Sra-1 (Figure S1(d)). Not
surprisingly, average protrusion velocities of these rare
examples of compromised lamellipodia were reduced as
compared to those mediated by wildtype Sra-1 (Figure S1
(f)). Together, all these datasets thus suggest that although
helpful, continuous Rac-WRC interactions at the plasma
are not absolutely obligatory for lamellipodium protrusion.
Generation of a cell line allowing further dissection
of the Rac-WRC signalling module
Next we asked whether Rac is essential for WRC-
mediated lamellipodia formation solely because of its
essential function in WRC activation or because of ser-
ving additional functions. To test this, we had to develop
cell systems in which endogenous WRC or Rac proteins
could be replaced by active variants of each or functional
deficiency mutants in a combinatorial fashion. In pre-
vious work, we had established cell lines lacking either
Rac1/2/3 or functional WRC (Sra-1/PIR121-null), in
which off-target effects potentially caused by CRISPR/
Cas9-mediated genome editing were excluded by
a combination of analysing multiple, independently gen-
erated clones as well as by rescue of phenotypes with
exogenous Rac and Sra-1, respectively [7]. In the current
work, we extended this approach to generate a novel cell
line disrupted for all five genes (Sra-1/PIR121+ Rac1/2/3
KO#3/11; Figure 1(a)). The latter now allows decipher-
ing Rac/WRC signalling in more detail. In these cells,
lamellipodia formation is strikingly dependent on exo-
genous expression of both Sra-1 and Rac1. While neither
expression of EGFP as control, EGFP-Sra-1 nor myc-
Rac1L61 alone facilitated lamellipodia formation in
these cells, co-transfection of EGFP-Sra-1 and myc-
Rac1L61 potently restored lamellipodia, indicating the
presence of lamellipodia in these cells to strictly require
both Rac and Sra-1 (Figure 1(b,c)). Notably, Rac1L61
expression in these WRC-deficient cells also caused
plasma membrane blebbing (Figure 1(b) for
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representative image), reminiscent of our previous
observations upon Rac microinjection upon WRC sub-
unit knockdown [15]. This phenotype was robust and
occurred at high frequency (45 ± 13% in Rac1L61
expressing cells vs. 13 ± 12% in EGFP-expressing con-
trols), although a precise, mechanistic understanding of
Figure 1. Generation of Sra-1/PIR121+ Rac1/2/3 KO cells.
(a) Western blotting of distinct cell lines to probe for expression levels of endogenous Sra-1/PIR121 and/or Rac GTPases. (b) Cell
morphologies of Sra-1/PIR121+ Rac1/2/3 KO cells (clone #3/11) expressing respective constructs, as indicated. Panels in top row show
stainings of the actin cytoskeleton with phalloidin, and middle and/or bottom row images show fluorescence of the same cells derived from
either EGFP or anti-myc antibody stainings, as indicated. (c) Quantification of lamellipodial phenotypes. EGFP-Sra-1 WCA* denotes
a construct rendering WRC constitutively active due to mutations relieving the autoinhibitory interaction of Sra-1 with the C-terminal WCA-
domain (hence WCA* or active WCA) of WAVE [7,18]. Lamellipodial actin networks that were generally small, narrow, irregular or displayed
multiple ruffles were defined as ‘“immature lamellipodia”’, as opposed to regular, fully developed lamellipodia. n gives number of cells
analysed, data correspond to arithmetic means ± SEM from at least three independent experiments. Statistical significance was assessed for
differences between percentages of cells with ‘no lamellipodia’ phenotype. ***p < 0.001 (two-sample, two-sided t-test).
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the phenomenon is currently lacking. To test if consti-
tutive activation of WRC would be sufficient to trigger
lamellipodia formation in the absence of Rac, we
expressed EGFP-tagged Sra-1WCA*. Surprisingly, how-
ever, EGFP-tagged Sra-1 WCA*, lacking the need for
Rac-mediated activation of WRC was still incapable of
driving lamellipodia formation in this cell line and con-
ditions. If comparing this result with constitutively
active WRCs compromised in Rac binding, but giving
rise to inefficient lamellipodia formation in Sra-1/
PIR121-KO cells ([7] and Figure S1(c,d)), two theoretical
explanations for this discrepancy are thinkable: Firstly,
the A + D site-mutated, active WRC used in Figure S1
can still inefficiently bind to endogenous Rac proteins
present in these cells. Alternatively, Rac possesses addi-
tional, essential functions absent in cells harbouring
active WRC but lacking endogenous Rac proteins (as
in Figure 1(b,c)). Future experiments will have to distin-
guish between these two possibilities.
Rac-related Rho GTPases fail to activate WRC, but
can substitute for Rac in the presence of activated
WRC
Up to this date, the literature contains conflicting
results concerning the relevance of the closest rela-
tives of Rac GTPases in mammals, in particular
RhoG, but to a certain extent also Cdc42. In spite
of prominent studies establishing functions for RhoG
in signalling complexes operating upstream of Rac
[10–12], RhoG has also already been concluded to
contribute to fibroblast migration independent of Rac
activation [23], although it has remained unclear how
that might occur mechanistically [24]. Of note, and
again in full accordance with our previously pub-
lished fibroblast data [6], our Rac1/2/3-deficient B16-
F1 melanoma line failed entirely to form lamellipodia
even upon expression of constitutively active RhoG
(Figure 2(a,b)). Identical results were obtained with
overexpressed, constitutively active Cdc42 but not
Rac1, which robustly restored lamellipodia formation
(Figure 2(a,b)), as expected [7]. Aside from the
incapability of Cdc42 to induce lamellipodia, we
found a prominent induction of stress fibres in
these conditions (Figure 2(a); 89 ± 2% of transfected
cells), which was not seen with RhoG (2 ± 3%). Such
an activity is traditionally still mostly attributed to
RhoA/B/C activity in the literature, and thus not
followed up further in the context of the current
study. However, since our previous efforts allowed
us to experimentally separate Rac-mediated WRC
activation from other potential functions ([7] and
see above), we wondered whether we might – in
analogy to Rac – be able to establish connections
between RhoG or Cdc42 activities and WRC function
independent of Rac-mediated WRC activation. For
this, we explored RhoG- or Cdc42-driven actin
Figure 2. Rac-related GTPases RhoG and Cdc42 fail to induce lamellipodia in the absence of Rac expression.
(a) Cell morphologies of Rac1/2/3 KO cells (clone #1) expressing EGFP-tagged GTPases, as indicated. (b) Quantification of lamellipodial
phenotypes was performed as described for Figure 1(c). n gives number of cells analysed, data correspond to arithmetic means ± SEM from
at least three independent experiments. Statistical significance was assessed for differences between percentages of cells with ‘no
lamellipodia’ phenotype. ***p < 0.001 (two-sample, two-sided t-test).
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cytoskeleton remodelling in cells exclusively harbour-
ing active WRC but lacking endogenous Rac GTPases
(see Figure 1). And indeed, co-transfection of active
(Q61L), myc-tagged RhoG or Cdc42 together with
Sra-1 WCA* led to partial rescue of lamellipodia
formation in Sra-1/PIR121+ Rac1/2/3 KO cells
(clone #3/11) (Figure 3(a,c) for representative images
and quantitations, respectively). While RhoG was
able to induce immature lamellipodia in more than
40% of transfected cells and even occasional, fully
developed lamellipodia, Cdc42 caused lamellipodia
formation only in a small subfraction of cells (see
Figure 3(a), asterisks, and Figure 3(c) for quantifica-
tion). Although the low frequency of Cdc42-mediated
induction of (at least immature) lamellipodia in cells
co-expressing Sra WCA* could not be ignored, it was
not significantly different statistically from cells co-
expressing constitutively active Cdc42 with wildtype
Sra-1 (not shown). This result was obtained with
two-sided, two-sample t-test, but when using
Fisher’s exact test also appropriate for comparing
two experimental groups (Cdc42 co-expression with
Sra-1 WT versus WCA*) falling into two categories
(with or without lamellipodia), the difference
between them turned out to be statistically significant
(p = 0.023). Moreover, both RhoG and Cdc42 were
capable, in principle, of driving accumulation of Sra-
1 WCA* at protrusion sites given that lamellipodia
were formed (Figure 3(b)). Specific Sra-1 WCA*
enrichment upon co-expression of both RhoG and
Cdc42 was also confirmed by linescan analyses of
respective images (Figure 3(b)). In contrast, co-
tranfection of Sra-1 WCA* with myc-tagged, consti-
tutively active RhoA (G14V) failed to stimulate
lamellipodia or lamellipodia-like structures in all
cells analysed (96 cells from 3 independent experi-
ments; Figure 3(a,c) for quantification). This was
consistent with the lack of any accumulation of
EGFP-tagged Sra-1 WCA* at the periphery of these
cells (Figure 3(b), right panel), in spite of constitu-
tively active RhoA clearly being functional in this
case, as evidenced by the expected, prominent stimu-
lation of stress fibres (Figure 3(a), right panels).
As already mentioned in the context of statistical
analysis, the ability of RhoG and Cdc42 to induce
lamellipodia in these experiments was strictly depen-
dent on constitutive WRC activity in this cell line
(through using Sra-1 WCA*), as both RhoG and
Cdc42 failed to induce lamellipodia when co-
expressed with WT-Sra-1 (Figure 3(c)). Finally, addi-
tional mutation of the two Rac binding sites on con-
stitutively active WRC completely prevented (in case
of Cdc42) or at least strongly inhibited (in case of
RhoG) the induction of lamellipodia in these condi-
tions (Figure 3(a,c)), indicating that the action of
RhoG/Cdc42 may be explained by direct, (Rho-
GTPase binding surface-dependent) interaction with
WRC. In line with this, immunoprecipitation experi-
ments showed clearly detectable interactions of RhoG
and Cdc42 with Sra-1 WCA*, albeit somewhat weaker
perhaps than observed for Rac1 (Figure 3(d)).
Assuming that the described, potential RhoG/Cdc42 -
WRC interactions may be direct, we also wondered
whether these GTPases might preferentially target the
A or the D site previously established as interaction
surfaces on WRC with Rac1 [19]. Due to the low
frequency of Cdc42-mediated lamellipodia formation
in this assay (Figure 3), we focused on RhoG in these
experiments compared to Rac1 used as control. We
again co-transfected our cell line lacking endogenous
WRC plus all Rac-GTPases with the individual A and
D site mutants of WCA* Sra-1 and constitutively
active Rac1 (as control) versus RhoG. While mutating
either the A or D site caused significant impairment of
lamellipodia formation induced by active Rac1, albeit
for distinct reasons, as expected (for comparison of
analogous, but not identical experiments, see ref [7].),
mutating the A site did not cause a statistically sig-
nificant reduction of RhoG-mediated lamellipodia for-
mation in this assay. In contrast, abrogation of D site
function caused a severe reduction of lamellipodia
(Figure S2(a)), virtually identical to the level observed
upon simultaneous mutation of both sites (Figure 3
(c)). From this, we concluded that the potential, per-
haps direct WRC-RhoG interaction is largely mediated
by the D site of Sra-1.
All these results prompted us to compare by addi-
tional in silico analyses the putative binding surfaces
of RhoG and Cdc42 with the D site of Sra-1, which
also constitutes the high affinity binding site for Rac
GTPases [19]. Sequence alignments revealed that two
(in case of RhoG) or three (in case of Cdc42) amino
acids differed from Rac1 in the putative binding
interface (Figure S2(b)). However, neither of these
residues caused significant changes in electrostatic
surface potentials (Figure S2(c)). RhoA, on the con-
trary, showed obvious differences in surface electro-
static potential in the putative binding interface,
particularly caused by the glutamine to valine sub-
stitution at position 33 in RhoA, the analogous sub-
stitution of which in Rac1 (E31V) apparently
interfered with proper lamellipodia formation [7,25].
Together, these data suggest that both RhoG and
Cdc42 can specifically interact with WRC, in princi-
ple, and in a physiologically relevant manner once
WRC has been activated by Rac1.
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Figure 3. Induction of lamellipodia by RhoG or Cdc42 in conjunction with activated WRC, but in the absence of Rac expression.
(a) Representative images of Sra-1/PIR121+ Rac1/2/3 KO cells (clone #3/11) expressing EGFP-Sra-1 WCA* together with myc-tagged, small
GTPases, as indicated. Transfected cells identified by myc-staining (asterisks) were analysed concerning their cell morphologies (top row, actin
filament staining with phalloidin) and the capability to accumulate active WRC (Sra-1 WCA*) at peripheral lamellipodia (b). Measurements shown
in b were performed along line scans as shown in the images provided in a (green lines). (c) Quantification of lamellipodial phenotypes, done as
described for Figure 1(c). n gives number of cells analysed, and differentially coloured columns are arithmetic means ± SEM from at least three
independent experiments. Statistical significance was assessed for differences between the percentages of cells with ‘no lamellipodia’ phenotype.
***p < 0.001 (two-sample, two-sided t-test). (d) Sra-1/PIR121 KO cells (clone # 3) were co-transfected withmCherry-Sra-1 WCA* and either EGFP or
constitutively active (Q61L), EGFP-tagged small GTPases, lysed and subjected to immunoprecipitation against EGFP. Note the complete absence of
immunoprecipitation of Sra-1 upon co-expression of EGFP alone (negative control), and significant interactions of Sra-1 WCA* with Rac-1, RhoG
and Cdc42. (e) Model for how RhoG and Cdc42 might regulate WRC and lamellipodia formation.
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Discussion
Although puzzling initially, we have previously found and
confirmed here using distinct experimental systems that
Rac may not have to associate with the plasma membrane
in order to activate or recruit WRC during lamellipodia
initiation and maintenance. Yet, and not inconsistent
with this view, Rac GTPases remain to be obligatory for
both WRC activation and lamellipodia formation, as cells
lacking both endogenous Rac GTPases and WRC can
only form lamellipodia upon additional, specific manip-
ulation. To our surprise, we establish for the first time
here that lamellipodia formation is possible, in principle,
without Rac GTPases, given that cells lack the need for
WRC activation (because it is already activated or does
not need to be activated), and that they over-express
constitutively active variants of either RhoG or Cdc42.
In other words, overexpression of RhoG, and to a lesser
extent Cdc42 can cause the accumulation of constitutively
active WRC even in the complete absence of endogenous
Rac GTPases, presumably causing WRC-dependent
Arp2/3 complex activation. This suggests that aside
from previously established signalling crosstalk between
Rac GTPases and RhoG/Cdc42 [8–10], the latter may
directly contribute to the maintenance and/or activity of
WRC at protruding lamellipodia edges once Rac has
managed to activate individual WRCs. It is thus thinkable
that RhoG and Cdc42 may directly support Rac signalling
by partially taking over Rac functions concerning WRC
positioning irrespective of WRC activation.
Consistent with this view, we have previously found
average turnover times for WRC subunits at the pro-
truding plasma membrane that certainly fit the hypoth-
esis of continuous activation events of Arp2/3
complexes, mediated by individual WRC units in
a Rho GTPase binding-dependent fashion [7]. Slow
turnover and molecular crowding of individual WRCs
at the membrane likely contributes to efficient Arp2/3
activation at these sites (see also [26,27]), last, not least
because efficient Arp2/3 complex activation was pre-
viously demonstrated to involve simultaneous engage-
ment of two WCA domains [28–30]. Therefore, it
seems plausible that efficient Arp2/3 complex activation
at the lamellipodium tip coincides with WRC cluster-
ing, with the latter being affected, at least in part, by
GTPase signalling.
The described, direct contribution of RhoG and
Cdc42 to WRC-mediated actin remodelling is also
found to occur in spite of at best weak or entirely non-
specific interactions of RhoG and Cdc42 with wildtype
WRC [6,12], as we show here that the situation changes
dramatically if constitutively active WRC is used, which
can be precipitated quite efficiently by both Rac-related
GTPases. Moreover, we also found that at least the
interaction of RhoG with WRC is largely mediated
through the D site of Sra-1 in WRC, and not the
A site (Figure S2(a)), established previously to be cru-
cial for WRC activation by Rac1 [7]. This then could
explain the complete failure of RhoG (and Cdc42) to
activate WRC in the absence of endogenous Rac
GTPases (Figures 2 and 3(c)). All these considerations
are also confirmed by sequence alignments and struc-
tural considerations concerning effector interaction
surfaces present on Rac1, RhoG and Cdc42 versus
RhoA (Figure S2). Future structural studies will be
needed to solidify the hypothesis of direct interactions
and explain why – if confirmed to be direct – the
comparably robust interaction of RhoG and Cdc42
with Sra-1 observed here cannot occur with inactive
WRC and/or translate into WRC activation.
Although the binding efficiency of RhoG and Cdc42 to
active WRC appeared comparable in immunoprecipita-
tion experiments, there was clearly measurable differences
between the efficiency of the output response (lamellipo-
dia in this case), the precise reasons for which remain to
be determined. Yet, the vast majority of both RhoG and
Cdc42-dependent lamellipodia formed in these condi-
tions (absence of endogenous Rac GTPases) were still
immature, clearly illustrating the relevance of Rac in for-
mation and turnover of these structures beyond its estab-
lished, essential function in WRC activation.
The novel cell system lacking endogenous Rac and
WRC proteins (B16-F1 Sra-1/PIR121+ Rac1/2/3 KO
clone #3/11) also harbours the potential of emphasizing
previously mentioned, but less well studied phenotypes
caused by active, small GTPases, indicative for the
commonly established, but chronically underestimated
complexity arising from Rho-GTPase crosstalk [31,32].
For instance, without WRC, Rac failed to induce lamel-
lipodia, but not infrequently caused plasma membrane
blebbing much less common to B16-F1 cells expressing
endogenous WRC and thus capable of lamellipodia
formation. Similar observations were previously
reported for overexpression of the Rac effector loop
mutant F37A [33], which we now consider to be
impaired in driving lamellipodia formation as a result
of compromised WRC interaction [7]. Whether this
blebbing activity arises from intrinsic, Rac-specific fea-
tures (i.e. requiring direct Rac-effector binding) or is
a more indirect result of crosstalk to RhoA/B/C signal-
ling remains unclear. Moreover, our preliminary obser-
vations also indicated that Cdc42 activities can
prominently funnel into contractile stress fibre forma-
tion if Rac signalling (or lamellipodia formation) is
missing. This could likely be mediated through signal-
ling to MRCK kinases, previously shown to cooperate
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with Rho-ROCK signalling [34–36], which hitherto
appeared less prevalent in our cell systems without
compromised lamellipodia formation (see [37,38]). As
the lamellipodia response seen with the Cdc42 –
(active) WRC combination was much less prominent
than seen for the RhoG – (active) WRC couple, it is
tempting to speculate that the stress fibre induction
phenotype mentioned above might interfere with
more robust lamellipodia formation. This might be
explained perhaps by the widely accepted and long-
standing antagonism between protrusion- (lamellipo-
dia) versus contractility-dependent (stress fibres) pro-
cesses [39,40]. Future experiments will have to reveal
whether this assumption is correct.
Whatever the case, our data add to the view that
systematic generation and side-by-side comparison of
Rho GTPase and effector knockouts in the same par-
ental cell line will continue to unfold mechanistic
insights into the intricacies of Rho signalling and cross-
talk relevant for actin remodelling processes.
Materials and methods
Cell culture
B16-F1 cell line was purchased from ATCC (CRL-6323,
sex:male). B16-F1 derived Sra-1/PIR121 KO cells (clone
#3), as well as Rac1/2/3 KO cells (clone #1) were as
described [7]. B16-F1 cells and derivatives were cultured
in DMEM (4.5 g/l glucose; Invitrogen), supplemented with
10% FCS (Gibco), 2mM glutamine (Thermo Fisher
Scientific) and penicillin (50 Units/ml)/streptomycin
(50 µg/ml) (Thermo Fisher Scientific). B16-F1 cells were
routinely transfected in 35 mm dishes (Sarstedt), using
0.5 µg DNA in total and 1 µl JetPrime for controls, and
1 µg DNA in total and 2 µl JetPrime for B16-F1-derived
knockout cells. After overnight transfection, cells were pla-
ted onto acid-washed, laminin-coated (25 µg/ml) coverslips
and allowed to adhere for at least 5 hours prior to analysis.
DNA constructs
pEGFP-C1 and – C2 vectors were purchased from
Clontech Inc. (Mountain View, CA, USA). pEGFP-
C2-Sra-1, and derived mutant constructs (i.e. WCA*,
A site WCA*, D site WCA*, A + D site WCA*) were
described previously [7] and correspond to the splice
variant CYFIP1a, sequence AJ567911. mCherry-
tagged Sra-1 WCA* was generated by swapping
EGFP with mCherry, kindly provided by Dr. Roger
Tsien (University of California at San Diego, La Jolla,
California, USA) using NheI/BsrGI restriction sites.
pRK5-myc-Rac1L61 and pRK5-myc-RhoAV14 were
kindly provided by Alan Hall and Laura Machesky
(CRUK Beatson Institute, Glashow, UK). Cdc42L61
(placental isoform) was synthesized by Eurofins
Genomics and cloned into pRK5-myc and pEGFP-
C1 vectors. pEGFP-C1-Rac1L61 and pRK5-myc-
RhoGL61 were as described [6,7]. For generation of
pEGFP-C1-RhoGL61, the corresponding DNA frag-
ment immobilized from pRK5-myc-RhoGL61 with
BamHI/EcoRI was ligated into pEGFP-C1 vector
digested with BglII/EcoRI. pRK5-myc-Rac1L61-
ΔCAAX was generated by site directed mutagenesis
using 5ʹ-GAGGAAGAGAAAATGACTGCTGTTGTA
AGTC-3ʹ as forward primer. The fidelity of all con-
structs was verified by sequencing.
CRISPR/Cas9-mediated genome editing
B16-F1 cells lacking functional CYFIP1 and CYFIP2 genes,
as well as Rac1, Rac2 and Rac3 genes were generated by
treating Sra-1/PIR121 KO cells (clone #3) with pSpCas9
(BB)-2A-Puro (PX459) vectors targeting Rac1, Rac2 and
Rac3 genes. Specifically, cells were co-transfected with
plasmids targeting ATGCAGGCCATCAAGTGTG
(Rac1/2) and ATGCAGGCCATCAAGTGCG (Rac3)
genomic regions as described [7]. After puromycin selec-
tion of transfected cells (3 days), cells were extensively
diluted and a few days later, macroscopically visible colo-
nies picked, to obtain single cell-derived clones. Derived
cell clones already lacking Sra-1/PIR121 were screened for
the additional absence of Rac expression by Western
Blotting (see Figure 1).
Western blotting
Preparation of whole cell lysates was performed essen-
tially as described [7]. Western blotting was carried out
using standard techniques. Primary antibodies used were
Sra-1/PIR121 [15], Rac1/3 (23A8, Merck), Rac2 [6],
GAPDH (6C5, Calbiochem) and GFP (clones 7.1 and
13.1, Roche). HRP-conjugated secondary antibodies
were purchased from Invitrogen. Chemiluminescence
signals were obtained upon incubation with ECL™ Prime
Western Blotting Detection Reagent (GE Healthcare),
and were recorded with ECL Chemocam imager (Intas,
Goettingen, Germany).
Immunoprecipitation
For EGFP-immunoprecipitation experiments, Sra-1/
PIR121 KO cells (clone #3) co-expressing EGFP alone
or EGFP-tagged variants of constitutively active (Q61L)
GTPases together with mCherry-tagged Sra-1 WCA*
were lysed with lysis buffer (1% Triton X-100,
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140 mM KCl, 50 mM Tris/HCl pH 7.4/50 mM NaF,
10 mM Na4P2O7, 2 mM MgCl2 and Complete Mini,
EDTA-free protease inhibitor [Roche]). Lysates were
cleared and incubated with GFP-Trap agarose beads
for 60 min. Subsequently, beads were washed three
times with lysis buffer lacking Triton X-100 and pro-
tease inhibitor, mixed with Laemmli buffer, boiled for
5 min and subjected to Western Blotting.
Fluorescence microscopy, phalloidin and antibody
stainings and quantification
B16-F1-derived cell lines were seeded onto laminin-
coated (25 µg/ml), 15 mm-diameter glass coverslips
and allowed to adhere for at least 5 hours. Cells were
fixed with pre-warmed, 4% paraformaldehyde (PFA) in
PBS for 20 min, and permeabilized with 0.05% Triton-
X100 in PBS for 30 sec.
PFA-fixed cell samples following transfections with
plasmids mediating expression of EGFP-tagged pro-
teins were counterstained with ATTO-594-conjugated
phalloidin (1:200). For stainings with myc antibodies,
permeabilized cells were blocked with 5% horse serum
and 1% BSA in PBS, followed by staining with mono-
clonal anti-myc antibody (9E10; undiluted, home-made
hybridoma supernatant). Primary antibodies were
visualized with Alexa Fluor 350-coupled anti-mouse
IgG. Linescans were generated using MetaMorph soft-
ware by drawing lines (width of 15 pixels) from inside
the cell and across the lamellipodium. For quantitation
of stress fibers or blebs, cells derived from three inde-
pendent experiments and stained for the actin cytoske-
leton with phalloidin were acquired using digital
imaging as described above, followed by manual cate-
gorization as positive or negative for these structures.
Time-lapse microscopy
Live cell imaging shown in Figure S1(c) was done with
Sra-1/PIR121 KO #3 cells transfected with respective
EGFP-tagged Sra-1 variants and migrating on laminin-
coated glass (25 µg/ml). Cells were observed in µ-Slide
4 well (Ibidi), and maintained in microscopy medium
(F12 HAM HEPES-buffered medium, Sigma), includ-
ing 10% FCS (Gibco), 2 mM glutamine (Thermo Fisher
Scientific) and penicillin (50 Units/ml)/streptomycin
(50 µg/ml) (Thermo Fisher Scientific). Conventional
video microscopy was performed on an inverted micro-
scope (Axiovert 100TV, Zeiss) equipped with an HXP
120 lamp for epifluorescence illumination, a halogen
lamp for phase-contrast imaging, a Coolsnap-HQ2
camera (Photometrics) and electronic shutters driven
by MetaMorph software (Molecular Devices). Live cell
images were obtained using a 100 x/1.4 NA Plan apoc-
hromatic oil objective at a frame rate of 12/min.
Kymographs were generated using MetaMorph soft-
ware by drawing lines from inside the cell and across
the lamellipodium, and the protrusion velocity deter-
mined by measuring the advancement of lamellipodia
tips over time.
In silico-comparison of binding interfaces of small
GTPases to the D site of Sra-1
Sequence alignments were carried out using http://
www.uniprot.org. The structure of RhoG was predicted
with Phyre2 [41]. For comparison of surface electro-
static potentials of different small GTPases, indicated
structures were superimposed with Rac1 occupying the
D site of Sra-1 [7,19] using CCP4MG.
Statistical analysis
To assess statistical significance, two-sided, two-sample
t-test was applied when data passed normality and equal
variance tests (i.e. in Figure 1(c), 2(b), 3(c), S1(b) and S2(a)),
otherwise nonparametric Mann-Whitney-Rank-Sum test
was performed (Figure S1(f)). Fisher’s exact test was con-
ducted for comparing cells with or without lamellipodia in
Sra-1/PIR121+ Rac1/2/3 KO#3/11 clone, co-expressing
Cdc42 with Sra-1 WT versus WCA* (Figure 3(c)).
Statistical analyses were performed using Sigma plot 12.0
(Systat Software). Observed differences between groups
were considered to be statistically significant if the error
probability (p-value) of this assumption was below 5%
(p < 0.05).
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